Serán Bioscience

Executive Summary

Serán Bioscience is a specialized Contract Development and Manufacturing Organization (CDMO) that applies a 'science-first' approach to advanced drug delivery for small molecules. Founded in 2008 and headquartered in Bend, Oregon, the company leverages proprietary spray drying and particle engineering technologies to improve bioavailability and enable scalable formulations from early development through commercial production. By addressing solubility and stability challenges, Serán helps pharmaceutical clients accelerate timelines and enhance therapeutic efficacy. As a private, pre-clinical stage firm, it competes within the growing CDMO market, focusing on complex oral and injectable formulations. While smaller than larger peers, its niche expertise in bioavailability enhancement positions it as a valuable partner for drug developers seeking to optimize their pipelines.

Upcoming Catalysts (preview)

• Q3 2026Major manufacturing contract with a top-20 pharma company40% success
• Q4 2026Capacity expansion announcement (e.g., new spray dryer facility)30% success
• Q2 2026Strategic partnership for co-development of a high-value formulation platform50% success